申请人:University of Louisiana at Lafayette
公开号:US20160304538A1
公开(公告)日:2016-10-20
The method relates to the field of asymmetric allylic amination and comprises preparing a chiral N-substituted allylic amine compound from the corresponding allylic substrates and substituted hydroxylamines, in the presence of a catalyst, said catalyst comprising copper compounds and a chiral ligand. Examples of chiral amine compounds which can be made using the method include Vigabatrin, Ezetimibe Terbinafine, Naftifine 3-methylmorphine, Sertraline, Cinacalcet, Mefloquine hydrochloride, and Rivastigmine. There are over 20,000 known bioactive molecules with chiral N-substituted allylic amine substructure. The method may also be used to produce non-natural chiral β-aminoacid esters, a sub-class of chiral N-substituted allylic amine compounds. Examples of β-aminoacid ester which can be produced by the disclosed method, include, but are not limited to, N-(2-methylpent-1-en-3-yl)benzenamine and Ethyl 2-methylene-3-(phenylamino)butanoate. Further, the products of the method described herein can be used to produce chiral heterocycles and bioactive molecules or materials. A novel chiral copper-BINAM nitrosoarene complex is also set forth.
该方法涉及不对称联烯胺化领域,包括在催化剂的存在下,从相应的联烯底物和取代羟胺制备手性N-取代联烯胺化合物,所述催化剂包括铜化合物和手性配体。使用该方法可以制备的手性胺化合物的示例包括Vigabatrin、Ezetimibe Terbinafine、Naftifine 3-methylmorphine、Sertraline、Cinacalcet、Mefloquine hydrochloride和Rivastigmine。已知具有手性N-取代联烯胺亚结构的生物活性分子超过20,000种。该方法还可用于生产非天然手性β-氨基酸酯,是手性N-取代联烯胺化合物的一个子类。公开方法可以生产的β-氨基酸酯的示例包括但不限于N-(2-甲基戊-1-烯-3-基)苯胺和乙酸乙酯2-亚甲基-3-(苯胺基)丁酸酯。此外,所述方法的产物可用于生产手性杂环和生物活性分子或材料。还提出了一种新型手性铜-BINAM硝基芳烃配合物。